Rankings
▼
Calendar
OMER FY 2013 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$826M
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-73.4% YoY
Gross Profit
-$17M
-1045.4% margin
Operating Income
-$51M
-3157.3% margin
Net Income
-$40M
-2487.3% margin
EPS (Diluted)
$-1.39
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$17M
Total Liabilities
$35M
Stockholders' Equity
-$18M
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$6M
-73.4%
Gross Profit
-$17M
$6M
-378.6%
Operating Income
-$51M
-$37M
-37.0%
Net Income
-$40M
-$38M
-3.5%
← FY 2012
All Quarters
FY 2014 →